BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 38517799)

  • 1. Treatment Approaches for Altered Facial Expression: A Systematic Review in Facioscapulohumeral Muscular Dystrophy and Other Neurological Diseases.
    Rasing NB; van de Geest-Buit WA; Chan OYA; Mul K; Lanser A; van Engelen BGM; Erasmus CE; Fischer AH; Ingels KJAO; Post B; Siemann I; Groothuis JT; Voermans NC
    J Neuromuscul Dis; 2024; 11(3):535-565. PubMed ID: 38517799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychosocial functioning in patients with altered facial expression: a scoping review in five neurological diseases.
    Rasing NB; van de Geest-Buit W; Chan OYA; Mul K; Lanser A; Erasmus CE; Groothuis JT; Holler J; Ingels KJAO; Post B; Siemann I; Voermans NC
    Disabil Rehabil; 2023 Sep; ():1-20. PubMed ID: 37752723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facing facial weakness: psychosocial outcomes of facial weakness and reduced facial function in facioscapulohumeral muscular dystrophy.
    van de Geest-Buit WA; Rasing NB; Mul K; Deenen JCW; Vincenten SCC; Siemann I; Lanser A; Groothuis JT; van Engelen BG; Custers JAE; Voermans NC
    Disabil Rehabil; 2023 Jul; 45(15):2507-2516. PubMed ID: 35815498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of the patient-reported "Facial Function Scale" for facioscapulohumeral muscular dystrophy.
    Mul K; Wijayanto F; Loonen TGJ; Groot P; Vincenten SCC; Knuijt S; Groothuis JT; Maal TJJ; Heskes T; Voermans NC; Engelen BGMV
    Disabil Rehabil; 2023 May; 45(9):1530-1535. PubMed ID: 35575310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acupuncture Improves the Facial Muscular Function in a Case of Facioscapulohumeral Muscular Dystrophy.
    Liu Y; Xiao F; Liang X
    J Acupunct Meridian Stud; 2019 Apr; 12(2):73-76. PubMed ID: 30508665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical therapy for Bell's palsy (idiopathic facial paralysis).
    Teixeira LJ; Valbuza JS; Prado GF
    Cochrane Database Syst Rev; 2011 Dec; (12):CD006283. PubMed ID: 22161401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotype may predict the clinical course of facioscapolohumeral muscular dystrophy.
    Ricci G; Cammish P; Siciliano G; Tupler R; Lochmuller H; Evangelista T
    Muscle Nerve; 2019 Jun; 59(6):711-713. PubMed ID: 30895627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of weakness of orofacial muscles on swallowing and communication in FSHD.
    Mul K; Berggren KN; Sills MY; McCalley A; van Engelen BGM; Johnson NE; Statland JM
    Neurology; 2019 Feb; 92(9):e957-e963. PubMed ID: 30804066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of aerobic exercise training and cognitive behavioural therapy on reduction of chronic fatigue in patients with facioscapulohumeral dystrophy: protocol of the FACTS-2-FSHD trial.
    Voet NB; Bleijenberg G; Padberg GW; van Engelen BG; Geurts AC
    BMC Neurol; 2010 Jun; 10():56. PubMed ID: 20591139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome Measures in Facioscapulohumeral Muscular Dystrophy Clinical Trials.
    Ghasemi M; Emerson CP; Hayward LJ
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experiences of patients with facioscapulohumeral dystrophy with facial weakness: a qualitative study.
    Sezer S; Cup EHC; Roets-Merken LM; Lanser A; Siemann I; Weikamp JG; Mul K; van Engelen BG; Satink T; Voermans NC
    Disabil Rehabil; 2022 Nov; 44(22):6775-6782. PubMed ID: 34529524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facioscapulohumeral Muscular Dystrophy.
    Mul K
    Continuum (Minneap Minn); 2022 Dec; 28(6):1735-1751. PubMed ID: 36537978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of
    Duranti E; Villa C
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The facioscapulohumeral muscular dystrophy - health index: Italian validation of a disease-specific measure of symptomatic burden.
    Carraro E; Greco LC; Lizio A; Beretta M; Pozzi S; Casiraghi J; Becchiati S; Beshiri F; Frisoni MC; Iossa F; Heatwole C; Sansone V
    Disabil Rehabil; 2024 May; 46(10):2130-2137. PubMed ID: 37194629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facioscapulohumeral Muscular Dystrophies.
    Wagner KR
    Continuum (Minneap Minn); 2019 Dec; 25(6):1662-1681. PubMed ID: 31794465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication adherence in patients with myotonic dystrophy and facioscapulohumeral muscular dystrophy.
    Fitzgerald BP; Conn KM; Smith J; Walker A; Parkhill AL; Hilbert JE; Luebbe EA; Moxley RT
    J Neurol; 2016 Dec; 263(12):2528-2537. PubMed ID: 27734165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pediatric case report and literature review of facioscapulohumeral muscular dystrophy type1.
    Xiao T; Yang H; Gan S; Wu L
    Medicine (Baltimore); 2021 Nov; 100(47):e27907. PubMed ID: 34964760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facioscapulohumeral Muscular Dystrophy European Patient Survey: Assessing Patient Reported Disease Burden and Preferences in Clinical Trial Participation.
    McNiff MM; Hawkins S; Haase B; Bullivant J; McIver T; Mitelman O; Emery N; Tasca G; Voermans N; Diaz-Manera J
    J Neuromuscul Dis; 2024; 11(2):459-472. PubMed ID: 38277300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic Variability Among Patients With D4Z4 Reduced Allele Facioscapulohumeral Muscular Dystrophy.
    Ruggiero L; Mele F; Manganelli F; Bruzzese D; Ricci G; Vercelli L; Govi M; Vallarola A; Tripodi S; Villa L; Di Muzio A; Scarlato M; Bucci E; Antonini G; Maggi L; Rodolico C; Tomelleri G; Filosto M; Previtali S; Angelini C; Berardinelli A; Pegoraro E; Moggio M; Mongini T; Siciliano G; Santoro L; Tupler R
    JAMA Netw Open; 2020 May; 3(5):e204040. PubMed ID: 32356886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strength training and aerobic exercise training for muscle disease.
    Voet NB; van der Kooi EL; van Engelen BG; Geurts AC
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD003907. PubMed ID: 31808555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.